Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel treatment for breast cancer available for licensing

Sep. 16, 1998

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Positive clinical data from temozolomide trials presented at European oncology meeting

Sep. 16, 1998

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

rAd/p21: an effective gene therapy approach for treating lung cancer

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...